01 July 1998
Placebo-controlled trial of l-arginine in the treatment of peripheral arterial obstructive disease patients
Maciej Sławński, Lidia Grodzińska, Elżbieta Kostka-Trąbka, Krzysztof Bieroń, Aleksandra Goszcz, Robert Jachym, Ryszard KorbutMed Sci Monit 1998; 4(4): CR640-645 :: ID: 502128
Abstract
20 patients with peripheral arterial obstructive disease (PAOD) participated in a blind placebo controlled study. They received infusions of saline (placebo) for seven consecutive days and for the next seven days, 60 mmol of L-arginine (L-ARG) intravenously. Following this i. v. therapy, they were treated with tablets of L-ARG at a dose of 1 g, 3 times per day for 21 days. After seven days of placebo treatment, an improvement in exercise tests, a rise in the ankle/arm pressure ratio (AAPR), and an increase of blood flow in both calves (claudicant and non-claudicant) were observed. However, these effects were much more significant following L-ARG infusions. Placebo did not affect platelet susceptibility and fibrinolysis in a significant manner. L-ARG infusions inhibited spontaneous ADP and collagen induced platelet aggregation and stimulated fibrinolysis. L-ARG caused a significant increase in cGMP blood concentration levels while saline had no such effect. Clinical effects were more intensive following a 3 weeks oral therapy with L-ARG, but the influence on platelet aggregability, fibrinolysis and cGMP did not appear to be stronger. Our results suggest that i.v. therapy followed by orally administered L-ARG may serve in the prevention and therapy of PAOD patients. These findings call for further controlled studies on a greater number of patients.
Keywords: peripheral arterial obstructive disease, treatment, L-arginine, Nitric Oxide, cGMP levels, platelet aggregability, Fibrinolysis
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
08 Mar 2024 : Animal Research
Modification of Experimental Model of Necrotizing Enterocolitis (NEC) in Rat Pups by Single Exposure to Hyp...Med Sci Monit In Press; DOI: 10.12659/MSM.943443
18 Apr 2024 : Clinical Research
Comparative Analysis of Open and Closed Sphincterotomy for the Treatment of Chronic Anal Fissure: Safety an...Med Sci Monit In Press; DOI: 10.12659/MSM.944127
08 Mar 2024 : Laboratory Research
Evaluation of Retentive Strength of 50 Endodontically-Treated Single-Rooted Mandibular Second Premolars Res...Med Sci Monit In Press; DOI: 10.12659/MSM.944110
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952